Surmodics and Abbott’s Drug-Coated Balloon for Peripheral Artery Disease Gets FDA Approval

Medical device and in vitro diagnostics technologies provider SurModic Inc. has announced that its new drug-coated balloon (DCB) SurVeil has been granted approval by the US Food and Drug Administration (FDA).

The balloon is designed for the treatment of patients with peripheral artery disease.

The approval comes after the FDA made several requests for additional data, which lengthened the approval process that began in 2021.